Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells may induce sustained remission in some people with relapsing-remitting multiple sclerosis . RRMS is the most common form of MS, a progressive autoimmune disease in which the immune system attacks the brain and spinal cord.
http://www.nih.gov/news/health/dec2014/niaid-29.htm
http://www.nih.gov/news/health/dec2014/niaid-29.htm
No comments:
Post a Comment